TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Branded Generics Market – By Therapeutic Application
1.3.2 Europe Branded Generics Market – By Distribution Channel
1.3.3 Europe Branded Generics Market – By Drug Class
1.3.4 Europe Branded Generics Market – By Formulation Type
1.3.5 Europe Branded Generics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Branded Generics Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Branded Generics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Popularity of Branded Generics
5.1.2 Rise in Government Initiatives for Promoting Branded Generics
5.2 Market Restraints
5.2.1 Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications
5.3 Market Opportunities
5.3.1 New Opportunities Owing to Product Differentiation
5.4 Future Trends
5.4.1 More Focus Upon Utility of Branded Generics by Healthcare Providers and Professionals
5.5 Impact Analysis
6. Branded Generics Market– Europe Analysis
6.1 Europe Branded Generics Market Revenue Forecast and Analysis
6.2 Europe Branded Generics Market, By Country - Forecast and Analysis
7. Europe Branded Generics Market Revenue and Forecast To 2028– by Therapeutic Application
7.1 Overview
7.2 Europe Branded Generics Market Revenue Share, By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology Market Revenue and Forecast to 2028 (US$ Billion)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.5 Diabetes
7.5.1 Overview
7.5.2 Diabetes Market Revenue and Forecast to 2028 (US$ Billion)
7.6 Neurology
7.6.1 Overview
7.6.2 Neurology Market Revenue and Forecast to 2028 (US$ Billion)
7.7 Gastrointestinal Diseases
7.7.1 Overview
7.7.2 Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.8 Dermatology Diseases
7.8.1 Overview
7.8.2 Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)
7.9 Analgesics and Anti-Inflammatory
7.9.1 Overview
7.9.2 Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)
7.10 Others
7.10.1 Overview
7.10.2 Others Market Revenue and Forecast to 2028 (US$ Billion)
8. Europe Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel
8.1 Europe Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)
8.2 Hospital Pharmacies
8.2.1 Overview
8.2.2 Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.3 Retail Pharmacies
8.3.1 Overview
8.3.2 Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.4 Online Pharmacies
8.4.1 Overview
8.4.2 Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
8.5 Drug Stores
8.5.1 Overview
8.5.2 Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9. Europe Branded Generics Market Analysis and Forecast to 2028 by Drug Class
9.1 Europe Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)
9.2 Alkylating Agents
9.2.1 Overview
9.2.2 Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.3 Antimetabolites
9.3.1 Overview
9.3.2 Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.4 Hormones
9.4.1 Overview
9.4.2 Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.5 Anti-hypertensive
9.5.1 Overview
9.5.2 Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.6 Lipid Lowering Drugs
9.6.1 Overview
9.6.2 Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.7 Anti-Depressants
9.7.1 Overview
9.7.2 Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.8 Anti-psychotics
9.8.1 Overview
9.8.2 Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.9 Anti-epileptic
9.9.1 Overview
9.9.2 Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
9.10 Others
9.10.1 Overview
9.10.2 Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
10. Europe Branded Generics Market Analysis and Forecast to 2028 – by Formulation Type
10.1 Overview
10.2 Europe Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)
10.3 Oral
10.3.1 Overview
10.3.2 Oral Market Revenue and Forecast to 2028 (US$ Billion)
10.4 Parenteral
10.4.1 Overview
10.4.2 Parenteral Market Revenue and Forecast to 2028 (US$ Billion)
10.5 Topical
10.5.1 Overview
10.5.2 Topical Market Revenue and Forecast to 2028 (US$ Billion)
10.6 Others
10.6.1 Overview
10.6.2 Others Market Revenue and Forecast to 2028 (US$ Billion)
11. Europe Branded Generics Market Revenue and Forecasts to 2028 Country Analysis
11.1 Overview
11.1.1 Europe: Branded Generics Market, by Country, 2022 & 2028 (%)
11.1.1.1 Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.1.1 Germany: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.1.2 Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.1.3 Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.1.4 Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.1.5 Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.2 France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.2.1 France: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.2.2 France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.2.3 France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.2.4 France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.2.5 France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.3 UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.3.1 UK: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.3.2 UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.3.3 UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.3.4 UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.3.5 UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.4 Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.4.1 Italy: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.4.2 Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.4.3 Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.4.4 Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.4.5 Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.5 Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.5.1 Spain: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.5.2 Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.5.3 Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.5.4 Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.5.5 Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.6 Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.6.1 Rest of Europe: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.6.2 Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.6.3 Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
11.1.1.6.4 Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
11.1.1.6.5 Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
12. Branded Generics Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 MYLAN N.V.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bausch Health Companies Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Lupin
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Sanofi
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 ASTRAZENECA PLC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Dr. Reddy's Laboratories
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Par Pharmaceuticals, INC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Sandoz International GMBH
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Aspen Holdings
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Hetero
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES.
Table 1. Germany: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 2. Germany: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 3. Germany: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 4. Germany: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 5. France: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 6. France: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 7. France: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 8. France: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 9. UK: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 10. UK: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 11. UK: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 12. UK: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 13. Italy: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 14. Italy: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 15. Italy: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 16. Italy: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 17. Spain: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 18. Spain: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 19. Spain: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 20. Spain: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 21. Rest of Europe: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)
Table 22. Rest of Europe: Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)
Table 23. Rest of Europe: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)
Table 24. Rest of Europe: Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic Developments Done By Companies
Table 27. Glossary of Terms